Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05968807
Other study ID # 1000080779
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date June 26, 2026

Study information

Verified date January 2024
Source The Hospital for Sick Children
Contact Samantha J. Anthony, PhD, MSW
Phone 416-813-7654
Email samantha.anthony@sickkids.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.


Recruitment information / eligibility

Status Recruiting
Enrollment 55
Est. completion date June 26, 2026
Est. primary completion date June 26, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Mentee Inclusion Criteria: - Parent of a patient under 18 years of age who received a solid organ transplant and is at least two months post-transplant, - Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and - English-speaking. Mentor Inclusion Criteria: - Parent of a patient under 21 years of age who received a solid organ transplant and is at least one year post-transplant, - Nominated by their child's healthcare team as a good candidate to act in the mentor role (e.g., good communication skills, positive adaptation and adjustment post-transplant, strong support network), - Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and - English-speaking. Exclusion Criteria: - Non-English speaking.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
iParent2Parent Program
iParent2Parent is an online peer support mentorship program that is based on the iPeer2Peer online peer support mentorship program, which has been established in multiple chronic disease populations as a self-management intervention, including in chronic pain and juvenile idiopathic arthritis populations. The iParent2Parent program connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship.

Locations

Country Name City State
Canada Hospital for Sick Children Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
The Hospital for Sick Children

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment rates and withdrawal rates How many participants were recruited and have withdrawn from the program on average over time. Baseline to study completion, an average of 1 year
Primary Adherence with the iParent2Parent program When the participant completes 10 audio or video calls over 12 weeks and 100% when all online outcome measures completed. Baseline to study completion, an average of 1 year
Primary Acceptability (Mentees) Whether the innovation is agreeable, palatable or satisfactory.
Measured via semi-structured interview or focus group.
Baseline to 12 weeks after baseline/immediately after the intervention
Primary Acceptability (Mentors) Whether the innovation is agreeable, palatable or satisfactory.
Measured via semi-structured interview or focus group.
Baseline to program completion, an average of one year
Primary Level of engagement with the iParent2Parent program (Mentees) Measured via semi-structured interview or focus group. Baseline to 12 weeks after baseline/immediately after the intervention
Primary Level of engagement with the iParent2Parent program (Mentors) Measured via semi-structured interview or focus group. Baseline to program completion, an average of one year
Primary Barriers and enablers of the iParent2Parent program (Mentees) Measured via semi-structured interview or focus group. Baseline to 12 weeks after baseline/immediately after the intervention
Primary Barriers and enablers of the iParent2Parent program (Mentors) Measured via semi-structured interview or focus group. Baseline to program completion, an average of one year
Secondary Parenting stress (Mentees and Mentors) Parental Stress Scale; 18-item questionnaire. Each question is scored on a scale from 1 to 5, with scores ranging from 18 to 90. An overall higher score means a worse outcome. Baseline to program completion, an average of one year
Secondary Psychological distress (Mentees and Mentors) General Anxiety Disorder-7; 7-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 21. An overall higher score means a worse outcome. Baseline to program completion, an average of one year
Secondary Psychological distress (Mentees and Mentors) Patient Health Questionnaire Depression Scale; 8-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 24. An overall higher score means a worse outcome. Baseline to program completion, an average of one year
Secondary Perceived social support (Mentees and Mentors) Short form version 2.0 of the PROMIS battery for: Social Isolation; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a worse outcome. Baseline to program completion, an average of one year
Secondary Perceived social support (Mentees and Mentors) Short form version 2.0 of the PROMIS battery for: Informational Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome. Baseline to program completion, an average of one year
Secondary Perceived social support (Mentees and Mentors) Short form version 2.0 of the PROMIS battery for: Emotional Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome. Baseline to program completion, an average of one year
Secondary Coping (Mentees and Mentors) Coping Health Inventory for Parents; 16-item questionnaire. Each question about coping behaviour is scored on a scale from 0 to 3, with a possible response of "Did not use" the coping behaviour. Scores range from 0 to 48. An overall higher score means a better outcome. Baseline to program completion, an average of one year
Secondary Family Functioning (Mentees and Mentors) Pediatric Quality of Life Inventory™ 2.0 Family Impact Module; 36-item questionnaire with 8 different sections: Physical Functioning, Emotional Functioning, Social Functioning, Cognitive Functioning, Communication, Worry, Daily Activities, and Family Relationships. Each question is scored on a scale from 0 to 4. Items are reverse-scored and linearly transformed to a 0-100 scale. An overall higher score means a better outcome. Baseline to program completion, an average of one year
See also
  Status Clinical Trial Phase
Terminated NCT03950414 - A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients Phase 1
Recruiting NCT05663463 - Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients N/A
Completed NCT05124509 - Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
Completed NCT05121142 - Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease Phase 1
Completed NCT01058239 - Bortezomib Plus Rituximab for EBV+ PTLD Phase 2
Withdrawn NCT03327987 - Early Flu Shots in SOT
Completed NCT04253548 - iPeer2Peer Pediatric Thoracic Transplantation N/A
Recruiting NCT05164016 - Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
Withdrawn NCT02464306 - Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection Phase 4
Completed NCT02165423 - Discharge to Home and Chronic Illness Care Pilot N/A
Completed NCT00907023 - Transition From Hospital to Home in Solid Organ Transplant (SOT) N/A
Recruiting NCT04613206 - High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients Phase 2
Recruiting NCT05550298 - Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Completed NCT00518778 - Fusariosis in Solid-Organ Transplant Recipients N/A
Active, not recruiting NCT04331275 - Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant Phase 2
Active, not recruiting NCT03482739 - Safety, Tolerability and Immunogenicity of a Nine-valent Human Papillomavirus (HPV) Vaccine in HIV and Transplant Patients Phase 3
Not yet recruiting NCT04721288 - REmote moBile Outpatient mOnitoring in Transplant 2.0 N/A
Completed NCT04844489 - Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People N/A
Active, not recruiting NCT03360682 - Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV‐1‐Infected Solid Organ Transplant Patients Phase 4